Amobarbital

Workplace drug testing, forensic toxicology investigations, clinical toxicology screening, and pain management compliance programs commonly include amobarbital, an intermediate-acting barbiturate and Schedule II controlled substance. UTAK’s barbiturates and comprehensive drugs of abuse panels contain amobarbital in both serum and urine matrices at multiple concentration levels, supporting immunoassay screening and GC-MS or LC-MS/MS confirmatory methods. Stock and custom barbiturate QC solutions can incorporate additional compounds including pentobarbital, phenobarbital, secobarbital, and butalbital to support controlled substance QC programs.